Virology
病毒学
基本信息
- 批准号:7685030
- 负责人:
- 金额:$ 18.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-06-15 至 2014-05-31
- 项目状态:已结题
- 来源:
- 关键词:AIDS/HIV problemAcquired Immunodeficiency SyndromeAddressArtsBiological AssayCell LineClinicalConsultationsContainmentDevelopmentEngineeringEnsureEnvironmentEquipmentFacultyFee-for-Service PlansFosteringGoalsGrantHIVHuman ResourcesImmunologicsImmunologyKnowledgeLaboratoriesLifeMethodsMissionMolecularMolecular BiologyNatureOperative Surgical ProceduresPathogenesisPhasePlasmidsPoliciesProteinsQuality ControlReagentRecombinant ProteinsRecombinantsResearchResearch PersonnelResourcesSafetyServicesSiteStrategic PlanningStructureSupervisionTechniquesTechnology TransferTrainingTraining and EducationVaccine ResearchViralViral VectorWorkbasecostexperiencegene cloninggenetically modified cellslaboratory facilitymultidisciplinaryprogramsprotein expressionsafety practicesuccesstoolvirologyvirus culture
项目摘要
The goals of the VC are to enable, broaden and enhance HIV/AIDS research by providing state-of-the-art BSL-2-3
laboratory facilities and equipment, experienced and dedicated professional staff, education, training, virology-specific
research materials and assays and protein expression capabilities, all to support multidisciplinary, investigator-initiated
basic and clinical HIV/AIDS research. Each of our specific aims represent significant value-added to HIV/AIDS
research and the overall CFAR mission as they (i) enable live HIV research among all UAB investigators, (ii) foster the
development of HIV/AIDS research by new investigators, (iii) broaden the research capabilities among CFAR faculty,
and (iv) encourage research that is translational and multidisciplinary in nature. The services of VC are integral to the
AIDS Center as they provide critical support to numerous multidisciplinary basic and clinical HIV/AIDS research
programs. The specific aims for the VC are as follows:
1. To provide and maintain state-of-the-art BSL 2-3 laboratory facilities that are necessary to conduct
"live" HIV research.
2. To provide safety education and training, and ongoing supervision for all faculty and staff that work in
the BSL 2-3 Laboratory.
3. To augment AIDS research capabilities through consultation, assay-specific training, and provision of
standardized assays and defined molecular and virologic reagents.
4. To develop specialized genetically engineered tools and assays, including cell lines and viral vectors,
to help address new and important investigative challenges in HIV/AIDS research.
5. To continue to offer CFAR investigators the molecular biology services, reagents, and training, that
allow a rapid progression from cloning of genes to structure and/or function studies of the gene
product.
This renewal application reflects important changes that have occurred in the academic HIV/AIDS environment
nationally and at UAB since this grant was last competitively renewed. The critical services of two cores that were
previously operated independently, the Central Virus Culture Core and the Molecular Biology Core, have been
combined into a single core that is now referred to as the Virology Core (VC). This strategy is based on similarities in
the nature of virology services offered by the two previous cores and is meant to ensure that we are able to retain and
continue to provide critical value-added services, while maximizing proficient utilization of precious CFAR resources.
VC 的目标是通过提供最先进的 BSL-2-3 来实现、扩大和加强 HIV/AIDS 研究
实验室设施和设备、经验丰富且敬业的专业人员、教育、培训、病毒学专业
研究材料和分析以及蛋白质表达能力,所有这些都是为了支持多学科、研究者发起的
艾滋病毒/艾滋病的基础和临床研究。我们的每一个具体目标都为艾滋病毒/艾滋病带来了巨大的附加值
研究和总体 CFAR 使命,因为它们 (i) 使所有 UAB 研究人员能够进行实时艾滋病毒研究,(ii) 促进
新研究者推动艾滋病毒/艾滋病研究的发展,(iii) 扩大 CFAR 教师的研究能力,
(iv) 鼓励转化性和多学科性质的研究。 VC 的服务是不可或缺的
艾滋病中心为众多多学科基础和临床艾滋病毒/艾滋病研究提供重要支持
程序。 VC的具体目标如下:
1. 提供并维护进行必要的最先进的 BSL 2-3 实验室设施
“现场”艾滋病毒研究。
2、对所有在校工作的教职员工进行安全教育和培训,并进行持续的监督。
BSL 2-3 实验室。
3. 通过咨询、特定检测培训和提供
标准化测定和明确的分子和病毒学试剂。
4. 开发专门的基因工程工具和检测方法,包括细胞系和病毒载体,
帮助应对艾滋病毒/艾滋病研究中新的重要调查挑战。
5. 继续为 CFAR 研究人员提供分子生物学服务、试剂和培训,
允许从基因克隆到基因结构和/或功能研究的快速进展
产品。
此更新申请反映了艾滋病毒/艾滋病学术环境中发生的重要变化
自从该补助金上次竞争性更新以来,在全国范围内和在 UAB 都得到了支持。两个核心的关键服务分别是
之前独立运作的中央病毒培养核心和分子生物学核心,已被
组合成一个核心,现在称为病毒学核心(VC)。该策略基于以下方面的相似之处:
前两个核心提供的病毒学服务的性质,旨在确保我们能够保留和
继续提供关键的增值服务,同时最大限度地熟练利用宝贵的CFAR资源。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOHN Christopher KAPPES其他文献
JOHN Christopher KAPPES的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOHN Christopher KAPPES', 18)}}的其他基金
The effects of masculinizing gender-affirming hormone therapy for transgender men on susceptibility to HIV-1 infection modelled ex vivo in cervical mucosal tissue
跨性别男性男性化性别肯定激素治疗对子宫颈粘膜组织离体 HIV-1 感染易感性的影响
- 批准号:
10748946 - 财政年份:2023
- 资助金额:
$ 18.6万 - 项目类别:
Elucidating mechanisms of HIV-1 mucosal transmission
阐明 HIV-1 粘膜传播机制
- 批准号:
9892706 - 财政年份:2020
- 资助金额:
$ 18.6万 - 项目类别:
Elucidating mechanisms of HIV-1 mucosal transmission
阐明 HIV-1 粘膜传播机制
- 批准号:
10428455 - 财政年份:2020
- 资助金额:
$ 18.6万 - 项目类别:
Elucidating mechanisms of HIV-1 mucosal transmission
阐明 HIV-1 粘膜传播机制
- 批准号:
10553626 - 财政年份:2020
- 资助金额:
$ 18.6万 - 项目类别:
Analysis of human uterine mucosal cells as targets of HIV-1 infection
人类子宫粘膜细胞作为 HIV-1 感染靶点的分析
- 批准号:
8925576 - 财政年份:2015
- 资助金额:
$ 18.6万 - 项目类别:
Single cycle reporter assay for quantifying HIV-1 Nab
用于量化 HIV-1 Nab 的单循环报告基因检测
- 批准号:
6694007 - 财政年份:2003
- 资助金额:
$ 18.6万 - 项目类别:
相似国自然基金
从CD4+、CD8+T细胞免疫活化分子及其上游调控因子表达探究健脾祛湿法治疗艾滋病免疫调节机制
- 批准号:81460716
- 批准年份:2014
- 资助金额:48.0 万元
- 项目类别:地区科学基金项目
HAART过程中HCV复制增强与肝细胞MAVS抗病毒通路的关系研究
- 批准号:81201286
- 批准年份:2012
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN)Scientific Leadership Center; ADMIN SUPPLEMENT
艾滋病毒/艾滋病干预青少年医学试验网络 (ATN) 科学领导中心;
- 批准号:
10855435 - 财政年份:2023
- 资助金额:
$ 18.6万 - 项目类别:
Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Scientific Leadership Center
艾滋病毒/艾滋病干预青少年医学试验网络 (ATN) 科学领导中心
- 批准号:
10595899 - 财政年份:2023
- 资助金额:
$ 18.6万 - 项目类别:
Hepatotoxic mechanisms of anti-HIV- and anti-COVID-19 drugs and substance use disorders
抗 HIV 和抗 COVID-19 药物和物质使用障碍的肝毒性机制
- 批准号:
10684434 - 财政年份:2023
- 资助金额:
$ 18.6万 - 项目类别:
The University of Miami AIDS Research Center on Mental Health and HIV/AIDS - Center for HIV & Research in Mental Health (CHARM)Research Core - Methods
迈阿密大学艾滋病心理健康和艾滋病毒/艾滋病研究中心 - Center for HIV
- 批准号:
10686544 - 财政年份:2023
- 资助金额:
$ 18.6万 - 项目类别: